Insights from 2023 SABCS


 

SABCS 2023 Insights: "Final iDFS Analysis From the NATALEE Trial - Ribociclib + NSAI as Adjuvant Treatment in Patients With HR+/HER2- eBC"

486 views
December 15, 2023
Comments 0
Login to view comments. Click here to Login